ALBUQUERQUE, N.M.--(BUSINESS WIRE)--The chief executive officer of cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) (www.biomoda.com) discussed top-line results of the company’s pilot clinical trial of the CyPath® diagnostic for lung cancer on nationally syndicated business radio talk shows airing on the Business Talk Radio Network (www.businesstalkradio.net/) and the Radio America Network (www.radioamerica.org) as well as Money Matters Radio (www.moneymattersradio.net) in the Boston market.
